Correlation Between Genscript Biotech and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Nuvalent, you can compare the effects of market volatilities on Genscript Biotech and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Nuvalent.
Diversification Opportunities for Genscript Biotech and Nuvalent
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Genscript and Nuvalent is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Nuvalent go up and down completely randomly.
Pair Corralation between Genscript Biotech and Nuvalent
Assuming the 90 days horizon Genscript Biotech is expected to under-perform the Nuvalent. In addition to that, Genscript Biotech is 1.03 times more volatile than Nuvalent. It trades about -0.03 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.08 per unit of volatility. If you would invest 3,048 in Nuvalent on November 5, 2024 and sell it today you would earn a total of 5,533 from holding Nuvalent or generate 181.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.4% |
| Values | Daily Returns |
Genscript Biotech vs. Nuvalent
Performance |
| Timeline |
| Genscript Biotech |
| Nuvalent |
Genscript Biotech and Nuvalent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Nuvalent
The main advantage of trading using opposite Genscript Biotech and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |